TRON News Alert Toron Inc (TRON) 0.0003 12/17/2014 01:48:40

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Toron Inc (TRON) 0.0003 $TRON

ZIVO Bioscience and WellMetris Subsidiary Announce Pilot Program and Pending Order for Point of Care Wellness Test
Marketwired - Tue Dec 02, 10:24AM CST
ZIVO Bioscience, Inc. (OTCQB: ZIVO), formerly Health Enhancement Products, Inc., and its WellMetris subsidiary announced today that Trion Solutions, Inc., a leading human resources company with over 1,000 clients, and 15,000 employees, has committed to a pilot program to evaluate the health and economic benefits offered by the Company's proprietary Wellness Profile testing platform. Five-hundred Trion employees will initially take the test, which measures several key areas of metabolic health, including lipid peroxidation, inflammation, hydration and nitrite/nitrate balance, among others.

United States: Residential Humidifier & Dehumidifier Market 2014
M2 - Fri Nov 28, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/6tvgkv/united_states) has announced the addition of the "United States: Residential Humidifier & Dehumidifier Market 2014" report to their offering. This report provides an overview of portable and whole-house humidifiers and dehumidifiers in the United States. Humidifiers- Equipment that increases the humidity (moisture) level in a room or entire house. Humidification is necessary in colder climate to add moisture to the air in dry weather. Dehumidifiers- Equipment that reduces the level of humidity in the air by removing the water vapor from the air. Dehumidifiers are used for health or comfort reasons and also in tight areas like crawl spaces, attic and basement to remove water, prevent mold and damp, musty odors. The study captures the following information: - Market Size, Growth Rate, Forecast 2011-2020 - Market Share Information - Growth Drivers & Challenges - Market Analysis: Residential Humidifiers & Residential Dehumidifiers - Supplier Landscape - Latest Developments & Market Trends Key Topics Covered: 1. Research Scope - Terms & Definitions 2. Market Landscape - Market Dynamics - Category Overview- Humidifier & Dehumidifier - Key Market Drivers & Restraints - Residential Humidifier Market - Residential Portable Humidifier Market: Revenue Forecasts, 2011-2020 - Market Share by revenue (Portable humidifier) - Residential Whole-House Humidifier Market: Revenue Forecasts, 2011-2020 - Market Share by revenue (Whole-house humidifier) - Residential Dehumidifier Market - Residential Portable Dehumidifier Market: Revenue Forecasts, 2011-2020 - Market Share by revenue (Portable Dehumidifier) - Residential Whole-House Dehumidifier Market: Revenue Forecasts, 2011-2020 - Market Share by revenue (Whole-house Dehumidifier) - US Residential Humidifier & Dehumidifier Market-Trends - Price Trends - Distribution - SWOT Analysis 3. Supplier Landscape - Leading Company Profiles - Latest Developments 4. Strategic Recommendations 5. Quotes by Industry Participants 6. Appendix Companies Mentioned - Aprilaire - Arctic King - Comfort Aire - Crane - Danby - De Longhi - Dri-Eaz - Essick Air - Friedrich Soleus - Frigidaire - GE - General Filters - Haier - Honeywell - Jarden - Kaz - LG - Lennox - Plaston - Skuttle and others - Sunpentown - Thermastor - Trion Air - Whirlpool - York For more information visit http://www.researchandmarkets.com/research/6t...ted_states
WHR: 174.43 (-8.93), HON: 96.38 (+0.57)

David Reid Joins Motiga as Senior Vice President, Publishing
Business Wire - Thu Sep 18, 8:10AM CDT
Motiga, the independent online game studio behind Gigantic, today announced David Reid has joined the company as Senior Vice President, Publishing. The move signifies the company's commitment to build world-class publishing infrastructure for Gigantic. Motiga has been stealthily working on Gigantic -- a free-to-play PC action game -- for two years, and after a successful showing at PAX Prime, has officially brought the game into public alpha testing. Reid joins Motiga's executive team alongside CEO and Co-Founder Chris Chung, CTO and Co-Founder Rick Lambright, and VP Product Development James Phinney.

FiltersFast.com Celebrates the Fourth of July with Special Shipping Offer
PRWeb - Mon Jul 07, 4:26AM CDT
In celebration of Independence Day Filtersfast.com, the leading online retailer of air and water filters, is offering customers another free shipping deal. This is to thank loyal customers by giving them one more reason to celebrate. All purchases on FiltersFast.com, of $50.00 or more, will be eligible to receive free shipping during this limited, promotional period of July 4 - July 7, 2014.
HON: 96.38 (+0.57)

Epithelial Ovarian Cancer - Pipeline Review, H1 2014
M2 - Tue Jun 24, 4:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5l7bgr/epithelial) has announced the addition of the "Epithelial Ovarian Cancer - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epithelial Ovarian Cancer and special features on late-stage and discontinued projects. Scope - The report provides a snapshot of the global therapeutic landscape of Epithelial Ovarian Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Epithelial Ovarian Cancer and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Epithelial Ovarian Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Epithelial Ovarian Cancer pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Companies Mentioned: - Boehringer Ingelheim GmbH - Amgen Inc. - Oxford BioMedica plc - Millennium Pharmaceuticals, Inc. - ImmunoGen, Inc. - Bayer AG - Pharmacyclics, Inc. - Prima BioMed Ltd. - Synta Pharmaceuticals Corp. - Oasmia Pharmaceutical AB - Glycotope GmbH - TRION Pharma GmbH - BioNumerik Pharmaceuticals, Inc. - CerRx, Inc. - Immunotope, Inc. - Pharma Mar, S.A. - VentiRx Pharmaceuticals, Inc. - Clovis Oncology, Inc. - Recepta Biopharma S.A. - California Stem Cell, Inc. - EGEN, Inc. - AbbVie Inc. - Sotio a.s. For more information visit http://www.researchandmarkets.com/research/5l7bgr/epithelial
SNTA: 2.66 (+0.02), PCYC: 129.56 (+1.12), CLVS: 53.28 (+0.09), IMGN: 9.83 (+0.43), AMGN: 159.44 (-0.16), ABBV: 65.25 (-0.37)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

dbt Labs Transforms Data Management with MetricFlow Open Source

Updated Category News Views 735

Embracing Open Source with MetricFlow In a groundbreaking move, dbt Labs recently announced its commitment to advancing trustworthy AI by open sourcing MetricFlow. This initiative represents a significant turning point in how organizations manage and utilize data in the era of artificial intelligence. The shift to an Apache 2.0 license not only safeguards the integrity of...

Continue Reading
EssilorLuxottica Achieves Euro 2 Billion Bond Issuance Success

Updated Category News Views 117

EssilorLuxottica's Successful Bond Issuance EssilorLuxottica has reached a noteworthy milestone by successfully issuing a Euro 2 billion bond at an attractive average rate of 2.99%. This strategic financial move highlights the company's strong position in the market and its appeal to investors. Details of the Bond Issuance The bond issuance features tenors of 4.5 years...

Continue Reading
Streamlined Home Selling Solutions Introduced in North Carolina

Updated Category News Views 292

Revolutionizing Home Selling in North Carolina Fair Cash Offers For Homes has recently launched its innovative service, ‘Sell Your House Fast North Carolina,’ designed to facilitate quick and efficient sales for homeowners. With the ever-changing real estate landscape, many individuals find themselves needing to sell their properties under various circumstances,...

Continue Reading
Ipsen Employee Admits to Insider Trading on Cancer Drug Deal

Updated Category News Views 268

Guilty Plea Tied to a Drugmaker’s Takeover Plans An employee at the French pharmaceutical company Ipsen has agreed to plead guilty to insider trading. The case, centered on trading ahead of a proposed acquisition, underscores the stakes around confidentiality in drug development and the pressures that test corporate governance. What Prosecutors Allege Dishant Gupta,...

Continue Reading
Oscar Health Achieves 52-Week Record with $23.45 Stock Price

Updated Category News Views 221

Oscar Health Achieves New Stock Performance Highs In a striking example of market resilience, Oscar Health, Inc. (OSCR) has reached an impressive 52-week high with its stock hitting $23.45. This achievement signifies a remarkable growth phase for the company, which has experienced an incredible one-year change of 288.51%. Investors have shown strong support for Oscar...

Continue Reading